Innate Pharma SA Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill
Innate Pharma SA (IPHYF) reported Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Intangible Assets
ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill · last filed 2026-04-01
| Period end | Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill 6 month | Acquisitions Through Business Combinations Intangible Assets Other Than Goodwill 12 month |
|---|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 0.00 EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 0.00 EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 0.00 EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 13.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 13.00K EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 264.00K EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 195.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 59.00K EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 44.21M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 40.23M EUR 20-F · filed 2020-04-24 |